Nanoscope Kickstarts BLA Submission for Restorative RP Therapy, Adds to Advisory Board
BLA filed, big brains recruited—Nanoscope is charging ahead with its promising gene-agnostic therapy for retinitis pigmentosa. Nanoscope Therapeutics (Texas, USA)…
FDA Grants Rare Pediatric Disease Designation to Ocugen’s Gene Therapy for Stargardt Disease
Ocugen’s OCU410ST gene therapy lands a rare badge of honor in the fight against IRDs. The U.S. Food and Drug…
popular posts
latest posts
